Bachem

Bachem is one of the largest producers of synthetic peptide active pharmaceutical ingredients (APIs) in the world. Out of the 80 approved peptide APIs available globally, Bachem has commercialized about one-third.

Our Good Manufacturing Practice (GMP) facilities are in Switzerland and the United States. They are regularly inspected by Swissmedic, the FDA, EMA, and other regulatory authorities to ensure high standards and quality.

Bachem aims to build long-term partnerships with customers. Our extensive experience in manufacturing large quantities of drug substances under GMP conditions and our strong regulatory background make us a preferred partner.

What Bachem Offers

With over 50 years of experience in developing, producing, and compiling data for Drug Master Files (DMFs), Bachem is known for being a reliable GMP manufacturer of new chemical entities (NCEs) and high-demand generic products.

We can produce peptide APIs from small gram amounts to hundreds of kilograms annually. Our quality management system oversees the entire production process, from starting materials to production, packaging, and delivery of the final product.

Our partners trust us to support and guide them in the commercial supply of GMP-manufactured NCEs and to maintain consistent quality in our generic APIs for their drug products.

About Bachem

Bachem is a leading, innovative company specializing in developing and manufacturing peptides and oligonucleotides. With over 50 years of experience, we provide products for research, clinical development, and commercial applications to pharmaceutical and biotechnology companies worldwide. We offer a wide range of services and operate internationally, with headquarters in Switzerland and locations in Europe, the US, and Asia. Bachem is listed on the SIX Swiss Exchange.